pediatric/adult hematologist with hemophilia focus, passionate to improve care for women/girls with bleeding disorders, clinical researcher, proud cheesehead
Proud of this study and the data it provides for peds hemophilia A patients as we strive for optimal health ❤️💉🩸
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A | New England Journal of Medicine https://t.co/lkxXRpOYaU
@EAHADnews - great conference filled with dear colleagues from around the globe and important data for the community. Thrilled to have had the chance to present!
Lynn Malec presents the latest from the XTEND-ed Phase 3 study! The second interim analysis reveals two-year clinical outcomes of once-weekly efanesoctocog alfa #prophylaxis in children with severe #haemophilia A. How does it impact bleed control and quality of life? #EAHAD2025
Lynn Malec presents the latest from the XTEND-ed Phase 3 study! The second interim analysis reveals two-year clinical outcomes of once-weekly efanesoctocog alfa #prophylaxis in children with severe #haemophilia A. How does it impact bleed control and quality of life? #EAHAD2025
Montgomery Educational Symposium on Hemostasis (MESH) was a huge success thanks to the incredibly bright minds and warm hearts that gathered to honor ‘Montgomery, Milwaukee’s’ amazing career @VersitiResearch
If experts like Dr. Lynn Malec are still learning about #jointhealth and #hemophilia, think about how much there is still to learn, and account for, for most patients.
If experts like Dr. Lynn Malec are still learning about #jointhealth and #hemophilia, think about how much there is still to learn, and account for, for most patients.
It is time for one of the most famous slides in #hemophilia to be updated. Paper in @JTHjournal describes prospectively collected bleeding rate data in 825 children with mild hemophilia. https://t.co/WelYY49itV
Check out publication by VBRI Senior investigator Qizhen Shi @QizhenShi and collaborators Anti-mCD20 in combination with α-mCXCL13 monoclonal antibody inhibits anti-FVIII antibody development in hemophilia… https://t.co/abE488aWXD
Interested in a Hematology position at Versiti? My biased opinion is our team is phenomenal 😉
Associate Medical Director/Medical Director, Versiti Medical Sciences Institute/CCBD- Adult and/or Med/Peds Hematologist (#Milwaukee, Wisconsin) #job https://t.co/DvQ7Gwv3nZ